Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
351
-
Total 13F shares, excl. options
-
54,301,590
-
Shares change
-
+1,067,036
-
Total reported value, excl. options
-
$8,892,764,640
-
Value change
-
+$176,201,808
-
Put/Call ratio
-
1.51%
-
Number of buys
-
180
-
Number of sells
-
-154
-
Price
-
$163.73
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2014
413 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q4 2014.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 351 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,301,590 shares
.
Largest 10 shareholders include FMR LLC (8,911,350 shares), PUTNAM INVESTMENTS LLC (7,792,204 shares), VANGUARD GROUP INC (3,477,267 shares), JANUS CAPITAL MANAGEMENT LLC (2,867,223 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1,933,296 shares), LONE PINE CAPITAL LLC (1,883,654 shares), BlackRock Institutional Trust Company, N.A. (1,476,998 shares), Westpac Banking Corp (1,455,087 shares), BlackRock Fund Advisors (1,336,178 shares), and State Street Corp (1,207,001 shares).
This table shows the top 351 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.